SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-13-002113
Filing Date
2013-05-01
Accepted
2013-05-01 07:31:32
Documents
6
Period of Report
2013-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k042713_soligenix.htm 8-K 39561
2 EXCLUSIVE CHANNEL COLLABORATION AGREEMENT f8k042713ex10i_soligenix.htm EX-10.1 424151
3 STOCK ISSUANCE AGREEMENT f8k042713ex10ii_soligenix.htm EX-10.2 176224
4 PRESS RELEASE f8k042713ex99i_soligenix.htm EX-99.1 33420
5 f8k042713ex99i_soligenix0.jpg GRAPHIC 6853
6 f8k042713ex99i_soligenix1.jpg GRAPHIC 5443
  Complete submission text file 0001213900-13-002113.txt   692064
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 13800374
SIC: 2834 Pharmaceutical Preparations